Caribou Biosciences (CRBU) Depreciation and Depletion (2020 - 2022)

Caribou Biosciences (CRBU) has 3 years of Depreciation and Depletion data on file, last reported at $400000.0 in Q2 2022.

• On a quarterly basis, Depreciation and Depletion rose 100.0% year-over-year to $400000.0 in Q2 2022; TTM through Jun 2022 was $301000.0, a 66.56% decrease from a year earlier, with the FY2021 full-year figure at $1000.0, down 99.89% from the prior year.
• Depreciation and Depletion for Q2 2022 stood at $400000.0, up from $300000.0 in the prior quarter.
• Over the last five years, Depreciation and Depletion for CRBU reached as high as $400000.0 in Q2 2022 and fell as low as -$699000.0 in Q4 2021.
• Historically, Depreciation and Depletion has averaged $155666.7 across 3 years, with a median of $200000.0 in 2020.
• Across the five-year window, Depreciation and Depletion plunged 449.5% in 2021 and surged 100.0% in 2022, its largest moves.
• Year by year, Depreciation and Depletion stood at $200000.0 in 2020, then plunged by 449.5% to -$699000.0 in 2021, then soared by 157.22% to $400000.0 in 2022.
• Per Business Quant data, the three most recent Depreciation and Depletion figures were $400000.0 in Q2 2022, $300000.0 in Q1 2022, and -$699000.0 in Q4 2021.